We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCI:NSEShipping Corporation of India Limited Analysis

Data as of 2026-07-31 - not real-time

₹291.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The Shipping Corporation of India trades around ₹291, comfortably above its 20‑day SMA (₹281) but just shy of the 50‑day SMA (₹295), indicating a short‑term bullish tilt. Technicals are supportive – RSI sits at a neutral 53, MACD shows a bullish crossover, and the price is holding above the identified support of ₹260 while eyeing resistance near ₹302. However, the balance sheet tells a different story: a debt‑to‑equity ratio of ~29.5, negligible operating cash flow, and zero ROE highlight severe profitability and liquidity constraints. The stock’s PE of ~10 is dramatically lower than the industry average of ~30, suggesting a valuation discount, yet the forward PE spikes to ~88, reflecting bleak earnings outlook. Dividend yield remains attractive at 4.7%, but the sustainability is doubtful given the weak cash generation and high leverage. In this mixed picture, the technical upside is tempered by fundamental fragility, making the stock a high‑risk, value‑oriented play with a strong dividend appeal that may not be durable.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram and price above 20‑day SMA
  • Attractive dividend yield of 4.7%
  • Support level comfortably below current price

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio limiting financial flexibility
  • Forward PE indicating sharply lower earnings expectations
  • Volatility of ~33% suggesting price swings

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained profitability issues (ROE and cash flow near zero)
  • Elevated leverage raising solvency concerns
  • Potential regulatory pressure on marine shipping emissions

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin1.10%
P/E Ratio10.0
Debt/Equity29.45
P/B Ratio1.5
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI53.6
Support₹260.20
Resistance₹302.00
MA 20₹281.85
MA 50₹295.39
MA 200₹262.31
MACDBullish
VolumeDecreasing
Fear & Greed Index91.27

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.70%

Risk Assessment

Beta0.81
Volatility33.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.